secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indivior Pharmaceuticals, Inc. (INDV)
CIK:        0001625297
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001628280-25-052210
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indivior proposes re-domestication from UK to Delaware; shareholder vote set for Dec 11, 2025
--------------------------------------------------------------------------------

- Scheme circular filed: EGM on Dec 11, 2025 to vote on re-domestication via scheme of arrangement.
- New holding company would be Indivior Pharmaceuticals, Inc. (Delaware); shares to trade on Nasdaq.
- Court approval and shareholder vote required; SEC registration exemption under Section 3(a)(10).
- Indivior shares expected to cease trading on Nasdaq before effective date; new shares commence same day.
- Board unanimously recommends voting in favor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625297/000162828025052210/0001628280-25-052210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625297/000162828025052210/indv-20251114.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-052210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer